Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily T member 10 (OR2T10) is a member of the olfactory receptor family, which are G protein-coupled receptors (GPCRs) involved in the detection of odorant molecules in the nose and initiation of neuronal responses leading to the perception of smell[3][6][5]. Olfactory receptors such as OR2T10 have a 7-transmembrane domain architecture similar to many neurotransmitter and hormone receptors and are encoded by single coding-exon genes[3][6][5]. The human olfactory receptor gene family is the largest in the genome. There is currently no established role for OR2T10 as a therapeutic target, disease biomarker, or known interacting drugs, and no specific safety concerns or use in patient biomarker strategies have been described[3][6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily T member 10 (OR2T10).